Trials / Completed
CompletedNCT05945797
Effects of Dexamethasone on Common Bile Duct Cannulation Time
Can Deep Common Bile Duct Cannulation Time During Endoscopic Retrograde Cholangiopancreatography Be Shortened by Dexamethasone
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Gujranwala medical college District Headquarters Hospital, Gujranwala · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main aim of this clinical trial is to evaluate the effects of dexamethasone on common bile duct cannulation time during endoscopic retrograde cholangiopancreatography (ERCP) in patients with biliary pathologies. The study will also study the effects of dexamethasone on total procedure time and total fluoroscopy time during ERCP. Participants will be divided into two groups, treatment group and placebo group. Patients in treatment group will receive dexamethasone and those in placebo group will be given normal saline before undergoing ERCP. The results in both groups will be compared to determine the effects of dexamethasone.
Conditions
- Common Bile Duct Diseases
- Common Bile Duct Calculi
- Common Bile Duct Stricture
- Common Bile Duct Neoplasms
- Common Bile Duct Dilatation
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone 4mg | An injection of 4mg of dexamethasone will be given to patients approximately 2 to 4 hours prior to the procedure of ERCP. |
Timeline
- Start date
- 2023-08-01
- Primary completion
- 2024-04-12
- Completion
- 2024-05-16
- First posted
- 2023-07-14
- Last updated
- 2025-03-21
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05945797. Inclusion in this directory is not an endorsement.